Autonomous Therapeutics, CEO, Dr. Ariel Weinberger, interviewed by Vaccine Nation about next-generation mRNA therapeutics and antivirals

Written by Ariel Weinberger

Autonomous Therapeutics CEO, Dr. Ariel Weinberger, is interviewed about the “the consequences of the mRNA revolution for therapeutics” and about the future of mRNA therapeutics from COVID-19 to cancers

Ariel Weinberger
Previous

Op-Ed in BioCentury: The urgent need for variant-proof therapeutics
Next

Autonomous CEO, Dr. Ariel Weinberger, presents on novel mRNA therapeutic technologies at the World Antiviral Congress